Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Senior Analyst, Product Management Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Skladiščnik (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 10, 2024
Revenue Deduction & Accounting Statutory Lead Warsaw Poland Finance CTS Audit & Finance Oct 10, 2024
Lead Consultant Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 10, 2024
Senior Consultant Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 10, 2024
Operater v proizvodnji farmacevtskih učinkovin (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Oct 10, 2024
RWE Lead Sintra Portugal International Innovative Medicines Market Access Oct 10, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
Senior Manager - Direct tax Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 10, 2024
Clinical Sourcing Manager, R&D Hyderabad (Office) India Operations CTS Procurement Oct 10, 2024
Analytical Expert (Associate Director, Science & Technology) Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 10, 2024
QC Team Leader - Microbiology Tuas Bay Lane Singapore Operations Innovative Medicines Quality Oct 10, 2024
Sr. Spec. DDIT GF Sol.Del. HCM Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Project Manager – Supply Chain Management Warsaw Poland Operations Innovative Medicines Technical Operations Oct 10, 2024
Quality Operations Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Oct 10, 2024
UX/UI Designer Prague Czech Republic Operations CTS Technology Transformation Oct 10, 2024
BPA (Budget & Planning Analyst) İstanbul Kurtköy Turkey Finance Innovative Medicines Audit & Finance Oct 10, 2024
Production Systems Expert İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Oct 10, 2024
LDC - Data Business Manager - Operations Prague Czech Republic Operations CTS Technical Operations Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
县域主任/县域主管 Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Oct 10, 2024
Head of MA South Guangzhou (Guangdong Province) China International Innovative Medicines Market Access Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
Senior Process Expert (m/f/d) - Temporary Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Yibin (Sichuan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Operations Innovative Medicines Others Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Senior Consultant – M&A Post-merger Integrations | Separations Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 09, 2024
Postdoc Patient-Centered Outcomes Basel (City) Switzerland Development Innovative Medicines Others Oct 09, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia